Fig. 7.
Adjusting for a variable (the collider – nonsteroidal antiinflammatory drug [NSAID]) that is influenced by an unmeasured cause of the exposure and an unmeasured cause of the outcome, creates a spurious noncausal pathway (A). The spurious pathway created (red) is M-shaped if variables are arranged in this pattern, and so this is sometimes referred to as M-bias. The unmeasured cause of propofol exposure might be clinician preferences (U1) and the unmeasured cause of mortality might be frailty or renal impairment (U2) which relatively contraindicates NSAID. If NSAID were thought to be a cause of mortality, then controlling for NSAID will simultaneously block a confounding pathway (B) and may be of net benefit.

Adjusting for a variable (the collider – nonsteroidal antiinflammatory drug [NSAID]) that is influenced by an unmeasured cause of the exposure and an unmeasured cause of the outcome, creates a spurious noncausal pathway (A). The spurious pathway created (red) is M-shaped if variables are arranged in this pattern, and so this is sometimes referred to as M-bias. The unmeasured cause of propofol exposure might be clinician preferences (U1) and the unmeasured cause of mortality might be frailty or renal impairment (U2) which relatively contraindicates NSAID. If NSAID were thought to be a cause of mortality, then controlling for NSAID will simultaneously block a confounding pathway (B) and may be of net benefit.

Close Modal

or Create an Account

Close Modal
Close Modal